A kinetic platform for in silico modeling of the metabolic dynamics in Escherichia coli

Advances and Applications in Bioinformatics and Chemistry

Volumn 3, Issue 1, 2010, Pages 97-110

  Barve, Aditya ^a   Gupta, Anvita ^b   Solapure, Suresh M ^b   Kumar, Ansu ^a   Ramachandran, Vasanthi ^b   Seshadri, Kothandaraman ^b   Vali, Shireen ^a   Datta, Santanu ^b  

^a Cellworks Research India Pvt Ltd   (India)

^b ASTRAZENECA   (United Kingdom)

Author keywords

Antibacterial drug; Escherichia coli; Kinetic platform; Mathematical model; Metabolic dynamics

Indexed keywords

BACTERIA (MICROORGANISMS); ESCHERICHIA COLI;

EID: 80051563598     PISSN: None     EISSN: 11786949     Source Type: Journal    
DOI: 10.2147/AABC.S14368     Document Type: Article

References (45)

1. Chan PF, Holmes DJ, Payne DJ. Finding the gems using genomic discovery: antibacterial drug discovery strategies - the successes and the challenges. Drug Discov Today Ther Strateg. 2004;1(4):519-527.
2. Payne DJ, Gwynn MN, Holmes DJ, Pompliano DL. Drugs for bad bugs: confronting the challenges of antibacterial discovery. Nat Rev Drug Discov. 2007;6(1):29-40.
3. Black MT, Bruton G. Inhibitors of bacterial signal peptidases. Curr Pharm Des. 1998;4(2):133-154.
4. Eisenthal R, Cornish-Bowden A. Prospects for antiparasitic drugs. The case of Trypanosoma brucei, the causative agent of African sleeping sickness. J Biol Chem. 1998;273(10):5500-5505.
5. Kohanski MA, Dwyer DJ, Hayete B, Lawrence CA, Collins JJ. A common mechanism of cellular death induced by bactericidal antibiotics. Cell. 2007;130(5):797-810.
6. Kaur P, Agarwal S, Datta S. Delineating bacteriostatic and bactericidal targets in mycobacteria using IPTG inducible antisense expression. PLoS One. 2009;4(6):e5923.
7. Datta S. Understanding the characteristics of a good anti-infective drug target. J Parasitic Dis. 1999;23:139-140.
8. Fong SS, Nanchen A, Palsson BO, Sauer U. Latent pathway activation and increased pathway capacity enable Escherichia coli adaptation to loss of key metabolic enzymes. J Biol Chem. 2006;281(12):8024-8033.
9. Walsh K, Koshland DE Jr. Branch point control by the phosphorylation state of isocitrate dehydrogenase. A quantitative examination of fluxes during a regulatory transition. J Biol Chem. 1985;260(14): 8430-8437.
10. Walsh K, Koshland DE Jr. Determination of flux through the branch point of two metabolic cycles. The tricarboxylic acid cycle and the glyoxylate shunt. J Biol Chem. 1984;259(15):9646-9654.
11. Holms H. Flux analysis and control of the central metabolic pathways in Escherichia coli. FEMS Microbiol Rev. 1996;19(2):85-116.
12. Wendisch VF, de Graaf AA, Sahm H, Eikmanns BJ. Quantitative determination of metabolic fluxes during coutilization of two carbon sources: comparative analyses with Corynebacterium glutamicum during growth on acetate and/or glucose. J Bacteriol. 2000;182(11):3088-3096.
13. Tweeddale H, Notley-McRobb L, Ferenci T. Effect of slow growth on metabolism of Escherichia coli, as revealed by global metabolite pool (" metabolome" ) analysis. J Bacteriol. 1998;180(19):5109-5116.
14. Purvis JE, Yomano LP, Ingram LO. Enhanced trehalose production improves growth of Escherichia coli under osmotic stress. Appl Environ Microbiol. 2005;71(7):3761-3769.
15. Baba T, Ara T, Hasegawa M, et al. Construction of Escherichia coli K-12 in-frame, single-gene knockout mutants: the Keio collection. Mol Syst Biol. 2006;2:2006-2008.
16. Chohnan S, Izawa H, Nishihara H, Takamura Y. Changes in size of intracellular pools of coenzyme A and its thioesters in Escherichia coli K-12 cells to various carbon sources and stresses. Biosci Biotechnol Biochem. 1998;62(6):1122-1128.
17. Song WJ, Jackowski S. Cloning, sequencing, and expression of the pantothenate kinase (coaA) gene of Escherichia coli. J Bacteriol. 1992; 174(20):6411-6417.
18. Zhang YM, Frank MW, Virga KG, et al. Acyl carrier protein is a cellular target for the antibacterial action of the pantothenamide class of pantothenate antimetabolites. J Biol Chem. 2004;279(49):50969-50975.
19. Tullius MV, Harth G, Maslesa-Galic S, Dillon BJ, Horwitz MA. A Replication-Limited Recombinant Mycobacterium bovis BCG vaccine against tuberculosis designed for human immunodeficiency virus-positive persons is safer and more efficacious than BCG. Infect Immun. 2008;76(11):5200-5214.
20. Dailey FE, Cronan JE Jr. Acetohydroxy acid synthase I, a required enzyme for isoleucine and valine biosynthesis in Escherichia coli K-12 during growth on acetate as the sole carbon source. J Bacteriol. 1986; 165(2):453-460.
21. Feist AM, Henry CS, Reed JL, et al. A genome-scale metabolic reconstruction for Escherichia coli K-12 MG1655 that accounts for 1260 ORFs and thermodynamic information. Mol Syst Biol. 2007;3:121.
22. Feist AM, Palsson BO. The growing scope of applications of genome-scale metabolic reconstructions using Escherichia coli. Nat Biotechnol. 2008;26(6):659-667.
23. Singh VK, Ghosh I. Kinetic modeling of tricarboxylic acid cycle and glyoxylate bypass in Mycobacterium tuberculosis, and its application to assessment of drug targets. Theor Biol Med Model. 2006;3:27.
24. Dwyer DJ, Kohanski MA, Hayete B, Collins JJ. Gyrase inhibitors induce an oxidative damage cellular death pathway in Escherichia coli. Mol Syst Biol. 2007;3:91.
25. Jorgensen CM, Hammer K, Jensen PR, Martinussen J. Expression of the pyrG gene determines the pool sizes of CTP and dCTP in Lactococcus lactis. Eur J Biochem. 2004;271(12):2438-2445.
26. Christopherson RI, Duggleby RG. Metabolic resistance: the protection of enzymes against drugs which are tight-binding inhibitors by the accumulation of substrate. Eur J Biochem. 1983;134(2):331-335.
27. Ingraham JL NF. Escherichia coli and Salmonella typhimurium: Cellular and Molecular Biology. 1st edition. American Society for Microbiology Press; 1987.
28. Karp PD, Keseler IM, Shearer A, et al. Multidimensional annotation of the Escherichia coli K-12 genome. Nucleic Acids Res. 2007;35(22): 7577-7590.
29. Davis MS, Cronan JE Jr. Inhibition of Escherichia coli acetyl coenzyme A carboxylase by acyl-acyl carrier protein. J Bacteriol. 2001;183(4): 1499-1503.
30. Heath RJ, Rock CO. Inhibition of beta-ketoacyl-acyl carrier protein synthase III (FabH) by acyl-acyl carrier protein in Escherichia coli. J Biol Chem. 1996;271(18):10996-11000.
31. Umbarger HE. Amino acid biosynthesis and its regulation. Annu Rev Biochem. 1978;47:532-606.
32. Favre R, Wiater A, Puppo S, Iaccarino M. Expression of a valine-resistant acetolactate synthase activity mediated by the ilv O and ilv G genes of Escherichia coli K-12. Mol Gen Genet. 1976;143(3):243-252.
33. Beyer A, Hollunder J, Nasheuer HP, Wilhelm T. Post-transcriptional expression regulation in the yeast Saccharomyces cerevisiae on a genomic scale. Mol Cell Proteomics. 2004;3(11):1083-1092.
34. Ishihama Y, Schmidt T, Rappsilber J, et al. Protein abundance profiling of the Escherichia coli cytosol. BMC Genomics. 2008;9:102.
35. Ishii N, Nakahigashi K, Baba T, et al. Multiple high-throughput analyses monitor the response of E. coli to perturbations. Science. 2007; 316(5824):593-597.
36. D W. The Physiology and Biochemistry of Prokaryotes. 2nd edition. Oxford University Press, USA; 1999.
37. Vali S, Chinta SJ, Peng J, et al. Insights into the effects of alpha-synuclein expression and proteasome inhibition on glutathione metabolism through a dynamic in silico model of Parkinson's disease: validation by cell culture data. Free Radic Biol Med. 2008;45(9):1290-1301.
38. Funahashi A, Morohashi M, Kitano H, Tanimura N. CellDesigner: a process diagram editor for gene-regulatory and biochemical networks. BIOSILICO. 2003;1(5):159-162.
39. Funahashi A, Matsuoka Y, Jouraku A, et al. CellDesigner 3.5: a versatile modeling tool for biochemical networks. Proceedings of the IEEE. 2008;96(8):1254-1265.
40. Kholodenko BN. Negative feedback and ultrasensitivity can bring about oscillations in the mitogen-activated protein kinase cascades. Eur J Biochem. 2000;267(6):1583-1588.
41. Peng L, Shimizu K. Global metabolic regulation analysis for Escherichia coli K-12 based on protein expression by 2-dimensional electrophoresis and enzyme activity measurement. Appl Microbiol Biotechnol. 2003; 61(2):163-178.
42. Liu M, Durfee T, Cabrera JE, et al. Global transcriptional programs reveal a carbon source foraging strategy by Escherichia coli. J Biol Chem. 2005;280(16):15921-15927.
43. Petranovic D, Mijakovic I. Photometric assay for measuring the intracellular concentration of branched-chain amino acids in bacteria. J Microbiol Methods. 2004;56(1):133-136.
44. LaRossa RA, Schloss JV. The sulfonylurea herbicide sulfometuron methyl is an extremely potent and selective inhibitor of acetolactate synthase in Salmonella typhimurium. J Biol Chem. 1984;259(14): 8753-8757.
45. Heinrikson RL, Meredith SC. Amino acid analysis by reverse-phase high-performance liquid chromatography: precolumn derivatization with phenylisothiocyanate. Anal Biochem. 1984;136(1):65-74.